Unknown PHASE4 INTERVENTIONAL 2-arm NCT01310465

The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody Fusion

Sponsor: Fudan University

Conditions Bone Mineral Density Bone Turnover Markers Image Changes of Lumbar Fusion

Interventions sodium chloride zoledronic acid

Updated 5 times since 2017 Last updated: Mar 7, 2011 Started: Jan 31, 2011 Primary completion: Dec 31, 2011 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01310465, this PHASE4 trial focuses on Bone Mineral Density and Bone Turnover Markers and remains ongoing. Sponsored by Fudan University, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Feb 2017 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fudan University

Data source: Fudan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China